Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial

OBJECTIVE: Identifying patients who may experience decreased or increased mortality risk from intensive glycemic therapy for type 2 diabetes remains an important clinical challenge. We sought to identify characteristics of patients at high cardiovascular risk with decreased or increased mortality ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Sanjay, Raghavan, Sridharan, Wexler, Deborah J., Berkowitz, Seth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829969/
https://www.ncbi.nlm.nih.gov/pubmed/29279299
http://dx.doi.org/10.2337/dc17-2252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829969/
https://www.ncbi.nlm.nih.gov/pubmed/29279299
http://dx.doi.org/10.2337/dc17-2252

Ejemplares similares